SMS Pharmaceuticals Limited (NSE:SMSPHARMA)
India flag India · Delayed Price · Currency is INR
356.60
+0.10 (0.03%)
Aug 21, 2026, 3:29 PM IST

SMS Pharmaceuticals Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-460.75413.99360.473.08465.83
Short-Term Investments
--0.910.770.7-
Cash & Short-Term Investments
460.75460.75414.91361.1673.78465.83
Cash Growth
10.79%11.05%14.88%389.52%-84.16%15.24%
Accounts Receivable
-2,1592,0322,3621,483485.19
Other Receivables
--153.63118.59171.14182.27
Receivables
-2,1592,1862,4811,655667.46
Inventory
-3,5122,8472,3372,2352,511
Prepaid Expenses
--70.5252.5449.3333.07
Other Current Assets
-248.6425.99107.3593.7893.17
Total Current Assets
-6,3805,5455,3394,1063,771
Property, Plant & Equipment
-6,5295,6554,6494,4374,476
Long-Term Investments
-262.83116.79109.38105.22215.27
Other Intangible Assets
-27.9621.326.614.6613.7
Other Long-Term Assets
-424.9188.85217.3132.32119.28
Total Assets
-13,62411,52710,3418,7968,595

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-1,2041,1391,5131,074649.92
Accrued Expenses
-9.25201.46124.2285.06118.26
Short-Term Debt
--1,2481,140937.89679.12
Current Portion of Long-Term Debt
-1,934465.92440.96375.91427
Current Portion of Leases
---5.929.410.4
Current Income Taxes Payable
-6.15----
Other Current Liabilities
-375.95189.1592.8966.5880.09
Total Current Liabilities
-3,5303,2443,3172,5491,965
Long-Term Debt
-1,7161,3941,2211,2111,495
Long-Term Leases
----6.1421.14
Pension & Post-Retirement Benefits
--2.573.788.049.94
Long-Term Deferred Tax Liabilities
-508.15480.98427.99410.2395.51
Other Long-Term Liabilities
-11.999.497.826.015.73
Total Liabilities
-5,7665,1304,9784,1913,892

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-93.6588.6584.6584.6584.65
Additional Paid-In Capital
--1,202698.18698.18698.18
Retained Earnings
--4,9314,2793,8073,905
Comprehensive Income & Other
-7,764174.25301.2515.515.5
Total Common Equity
7,8587,8586,3965,3634,6054,703
Minority Interest
-00---
Shareholders' Equity
7,8587,8586,3965,3634,6054,703
Total Liabilities & Equity
-13,62411,52710,3418,7968,595

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
3,6503,6503,1082,8082,5412,633
Net Cash (Debt)
-3,190-3,190-2,693-2,447-2,467-2,167
Net Cash Growth
------
Net Cash Per Share
-34.40-34.87-30.37-28.90-29.14-25.60
Filing Date Shares Outstanding
93.7693.6588.6584.6584.6584.65
Total Common Shares Outstanding
93.7693.6588.6584.6584.6584.65
Working Capital
-2,8502,3012,0221,5571,806
Book Value Per Share
83.9183.9172.1563.3654.4055.56
Tangible Book Value
7,8307,8306,3755,3374,5914,689
Tangible Book Value Per Share
83.6183.6171.9163.0454.2355.39
Land
--42.1342.1342.1342.13
Buildings
--1,5661,3411,3081,300
Machinery
--5,9054,8414,3314,279
Construction In Progress
--346.71302.72331.91110.04